Overview

Study of Vintafolide (MK-8109, EC145) in Participants With Advanced Ovarian and Endometrial Cancers (MK-8109-007, EC-FV-02)

Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
This is a Phase II clinical trial evaluating the benefit from therapy with vintafolide in participants with advanced ovarian and endometrial cancers.
Phase:
Phase 2
Details
Lead Sponsor:
Endocyte
Treatments:
Folic Acid
Vinca Alkaloids